This article was originally published in The Gray Sheet
Bone growth stimulator labeling change approved via premarket approval application supplement eliminates limitation for use in healing only non-union fractures that are at least nine months post-trauma. Under the revised labeling, "a fracture is considered non-union when the fracture site shows no visibly progressive signs of healing," the firm says in a June 18 release
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.